Nigeria Records 395 Cases Of Circulating Mutant Poliovirus Type 2

The National Primary Healthcare Development Agency (NPHCDA) has confirmed 395 new cases of Circulating Mutant Poliovirus Type 2 (cMPV2) across 27 states and the Federal Capital Territory (FCT).

NPHCDA Executive Director, Dr Faisal Shuaib, disclosed this in a statement on Thursday, saying the outbreak was a result of the immunity gaps in children.

He attributed this to low routine immunisation coverage and the suspension of several polio campaigns at the heat of the COVID-19 pandemic.

Dr Faisal, however, stated that the circulating mutant Polio-Virus Type 2 recorded in the 27 states and Abuja was different from the wild poliovirus, which the World Health Organisation gave its Polio Free Certification to Nigeria in 2020.

He gave the assurance that the NPHCDA would scale up routine immunisation, especially in the affected states in order to curb the spread of the circulating mutant Polio-Virus Type 2.

READ ALSO: Ernest Shonekan: Buhari, Sanwo-Olu, Others Pay Condolence Visit To Late Leader’s Family

Read the full statement below:

CIRCULATING MUTANT POLIO VIRUS TYPE2 (cMPV2) OUTBREAKS

The attention of NPHCDA and Development Partners has been drawn to reports in some sections of the media claiming that there is an outbreak of a new polio virus in some states.

For the avoidance of doubt, no case of Wild Polio Virus (WPV) has been reported anywhere in the country since the last case in 2016. We currently have 395 cases of Circulating Mutant Poliovirus Type 2 (cMPV2) across 27 states and the FCT.

Nigeria and the African region were certified Wild Polio Virus (WPV) free in 2020, following a rigorous verification and certification process by the African Regional Commission for the Certification of Poliomyelitis Eradication (ARCC) which spanned three years of no detection of WPV. Till date, there has been no case of WPV anywhere in the country.

cMPV2 outbreaks are caused by immunity gaps in children due to several reasons, including low routine immunization coverage, and missing children during immunization campaigns.

The suspension of several polio campaigns and other health programmes in 2020, as well as disruptions to routine immunization because of the COVID-19 pandemic, created further immunity gaps which led to new and wider outbreaks, and further increased transmission of the circulating mutant poliovirus both globally and within Nigeria.

The viruses thrive in areas with poor sanitation, open defecation, and inadequate access to clean drinking water. These have allowed the virus to be easily transmitted from one person to another through contaminated water and poor sewage disposal.

Malnutrition occasioned by increasing poverty is also a predisposing factor in exposed children. These non-wild polio viruses which originated because of normal changes in the reproduction of viruses in the environment are not as virulent as WPV and are also being reported in many other countries.

Working with our Donors and Development Partners, Nigeria has already acquired new tools and resources to ensure the outbreaks are contained through very robust outbreak responses using the novel Oral Polio Vaccine (nOPV2) which has been shown to be effective in halting the spread of the cMPV2.

All 36 States and FCT have completed at least one nOPV2 Outbreak Response (OBR). Several other rounds of the OBR as well as other campaigns to improve the mucosal immunity of children aged o-5 years old using Injectable Polio Vaccine (IPV) have also been planned for this year.

Efforts are also being ramped up to increase routine immunization coverage beyond pre-COVID values.

NPHCDA assures Nigerians that the Agency and Partners will continue to conduct surveillance and vaccination campaigns to prevent and contain any possible importation of the Wild Polio Virus into the country.

We use this opportunity to reiterate the importance of parents and caregivers bringing their children for routine immunization against vaccine preventable diseases.

Signed:

Dr Faisal Shuaib

Executive Director/CEO